People who may need dual-pathway metabolic support Tirzepatide may be a good fit if your provider thinks your body may benefit from support through both GLP-1 and GIP pathways
The maximum dosage depends on the formulation your doctor prescribes
La dicitura C(nn) indica un farmaco non ancora negoziato ai fini della rimborsabilit: resta comunque a carico del paziente
GLP-1 binds and activates the GLP-1 receptors to enhance insulin secretion and synthesis from the pancreas by promoting beta cells, suppressing glucagon secretion, slowing gastric emptying, and reducing food intake by decreasing appetite
Biochemical and biophysical research communications , 54 (2), 562-6
Kossoy G, Anisimov VN, Ben-Hur H, Kossoy N, Zusman I